The ω‐3 epoxide of eicosapentaenoic acid inhibits endothelial cell proliferation by p38 MAP kinase activation and cyclin D1/CDK4 down‐regulation

Overview of attention for article published in British Journal of Pharmacology, January 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter: 1 X user

patent: 6 patents

Readers on

mendeley: 27 Mendeley

So far, Altmetric has seen 6 patents that reference this research output.

Docosahexaenoic acid endocannabinoid epoxide derivative compositions

Grant US-11472787-B2

United States of America

18 Oct 2022

Derivatives of EPA endocannabinoid epoxides as anti-inflammatory, anti-cancerous, anti-angi…

Grant US-11407728-B2

United States of America

09 Aug 2022

Stable analogs of CYP450 lipid metabolites and inhibitors of soluble epoxide hydrolase

Grant US-10758511-B2

United States of America

01 Sep 2020

CYP450 lipid metabolites reduce inflammation and angiogenesis

Grant US-10413518-B2

United States of America

17 Sep 2019

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 2 additional patents.